Delta Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$242K Sell
3,988
-256
-6% -$14.9K 0.04% 235
2025
Q4
$229K Buy
+4,244
New +$204K 0.04% 252
2025
Q2
Sell
-4,031
Closed -$246K 241
2025
Q1
$246K Sell
4,031
-497
-11% -$29K 0.05% 212
2024
Q4
$256K Hold
4,528
0.05% 214
2024
Q3
$234K Buy
+4,528
New +$212K 0.05% 217
2024
Q2
Sell
-4,383
Closed -$238K 219
2024
Q1
$238K Sell
4,383
-132
-3% -$6.72K 0.05% 192
2023
Q4
$232K Sell
4,515
-202
-4% -$10.6K 0.06% 178
2023
Q3
$274K Hold
4,717
0.08% 149
2023
Q2
$302K Hold
4,717
0.08% 135
2023
Q1
$327K Sell
4,717
-17
-0.4% -$1.2K 0.09% 122
2022
Q4
$341K Buy
4,734
+2
+0% +$151 0.11% 123
2022
Q3
$336K Buy
4,732
+480
+11% +$34.8K 0.15% 99
2022
Q2
$327K Hold
4,252
0.15% 92
2022
Q1
$311K Hold
4,252
0.09% 109
2021
Q4
$265K Hold
4,252
0.08% 146
2021
Q3
$252K Hold
4,252
0.08% 149
2021
Q2
$284K Buy
4,252
+20
+0.5% +$1.3K 0.08% 146
2021
Q1
$267K Hold
4,232
0.09% 140
2020
Q4
$262K Sell
4,232
-40
-0.9% -$2.46K 0.08% 154
2020
Q3
$257K Buy
4,272
+40
+0.9% +$2.41K 0.14% 98
2020
Q2
$248K Sell
4,232
-30
-0.7% -$1.79K 0.1% 119
2020
Q1
$237K Sell
4,262
-1,383
-24% -$84.5K 0.18% 70
2019
Q4
$362K Buy
5,645
+991
+21% +$56.8K 0.13% 87
2019
Q3
$236K Sell
4,654
-609
-12% -$28.6K 0.12% 93
2019
Q2
$238K Buy
+5,263
New +$245K 0.14% 98

Other funds holding BMY

Delta Investment Management's BMY Position: Q1 2026 in Review

Delta Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 6% in Q1 2026, selling an estimated $14.9K and leaving 3,988 shares worth $242K. The position accounts for 0.04% of the portfolio, ranked #235.

Delta Investment Management first reported a position in BMY in Q2 2019 and has held it in 25 quarters since. The position peaked at $362K in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Delta Investment Management held 3,988 shares of Bristol-Myers Squibb worth $242K as of Q1 2026.
  • Delta Investment Management sold 256 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.9K.
  • Bristol-Myers Squibb made up 0.04% of Delta Investment Management's portfolio in Q1 2026, its #235 holding.
  • Delta Investment Management first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 25 quarters since.
  • Delta Investment Management's Bristol-Myers Squibb position peaked at $362K in Q4 2019.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Delta Investment Management's 13F filing for Q1 2026, filed 13 May 2026.